切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2016, Vol. 02 ›› Issue (01) : 59 -62. doi: 10.3877/cma.j.jssn.2096-1537.2016.01.013

所属专题: 文献

综述

静脉-静脉体外膜氧合与静脉-动脉体外膜氧合的应用时机:如何把握
王毅1, 潘鹏飞2, 于湘友1,*,*()   
  1. 1. 830054 乌鲁木齐,新疆医科大学第一附属医院重症医学科
    2. 404000 重庆三峡中心医院重症医学科
  • 收稿日期:2016-01-23 出版日期:2016-02-28
  • 通信作者: 于湘友

V-V extracorporeal membrane oxygenation and V-A extracorporeal membrane oxygenation

Yi Wang1, Pengfei Pan2, Xiangyou Yu1()   

  1. 1. Department of Critical Care Medicine, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
    2. Department of Critical Care Medicine, Chongqing Three Gorges Central Hospital, Chongqing 404000, China
  • Received:2016-01-23 Published:2016-02-28
  • Corresponding author: Xiangyou Yu
  • About author:
    Corresponding author : Yu Xiangyou: Email:
引用本文:

王毅, 潘鹏飞, 于湘友. 静脉-静脉体外膜氧合与静脉-动脉体外膜氧合的应用时机:如何把握[J]. 中华重症医学电子杂志, 2016, 02(01): 59-62.

Yi Wang, Pengfei Pan, Xiangyou Yu. V-V extracorporeal membrane oxygenation and V-A extracorporeal membrane oxygenation[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2016, 02(01): 59-62.

随着体外膜氧合(ECMO)技术临床应用经验的积累以及材料技术学科的进步,其临床适应证逐步扩大,但循证医学证据并未明确该技术能带来患者的生存益处,对ECMO应用时机把握不准确可能是重要影响因素之一。要想把握好ECMO的应用时机,充分理解适应证和禁忌证是基础,最优的常规治疗是前提,个体化评估是保证。本文将结合静脉静脉(vein-vein,V-V)ECMO和静脉动脉(vein- artery,V-A)ECMO的常见临床适应证,初步回顾与探讨ECMO的应用时机问题。

Extracorporeal membrane oxygenation(ECMO) therapy has widely used in the past decade. Improvement in technology has made ECMO safer and easier. But there are no trials showing the merits of ECMO in improving survival or quality of life of patients. The time for its application is the most important influencing factor. Before application, it is important to define the indications and contraindications and adequate conventional treatment and individualized assessments are the prerequisites. This review summarizes the current knowledge about the two basic veno-venous and veno-arterial ECMO systems and describes some of controversies in this field.

[1]
Chauhan S, Subin S. Extracorporeal membrane oxygenation, an anesthesiologist's perspective: physiology and principles[J]. Ann Card Anaesth, 2011, 14(3):218–229.
[2]
Gerke AK, Tang F, Cavanaugh JE, et al. Increased trend in extracorporeal membrane oxygenation use by adults in the United States since 2007[J]. BMC Res Notes, 2015, 8:686.
[3]
Hill JD, O'Brien TG, Murray JJ, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure(shock-lung syndrome). Use of the Bramson membran elung[J]. N Engl J Med, 1972, 286(12):629–634.
[4]
Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospectivestudy[J]. JAMA, 1979, 242(20):2193–2196.
[5]
UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. UK Collaborative ECMO Trail Group[J]. Lancet, 1996, 348(9020):75–82.
[6]
Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure(CESAR): a multicentre randomised controlled trial[J]. Lancet, 2009, 374(9698):1351–1363.
[7]
Hosmane SR, Barrow T, Ashworth A, et al. Extracorporeal membrane oxygenation: a radiologists' guide to who, what and where[J]. Clin Radio, 2015, 70(5):e58–e66.
[8]
Butt W, Maclaren G. Extracorporeal membrane oxygenation[J]. Prime Reports, 2013, 5:55–61.
[9]
Cerretelli P, Samaja M. Acid-base balance at exercise in normoxia and in chronic hypoxia. Revisiting the "lactate paradox"[J]. Eur J Appl Physiol, 2003, 90(5–6):431–448.
[10]
Guerin C, Reignier J, Richard JC, et al. Pronepositioning in severe acute respiratory distress syndrome[J]. N Engl J Med, 2013, 368(12):2159–2168.
[11]
Ferguson ND, Fan E, Camporota L, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material[J]. Intensive Care Med 2012, 38(10):1573–1582.
[12]
Grasso S, Terragni P, Birocco A, et al. ECMO criteria for influenza A(H1N1)- associated ARDS: role of transpulmonary pressure[J]. Intensive Care Med, 2012, 38(3):395–403.
[13]
Richard C, Argaud L, Blet A, et al. Extracorporeal life support for patients with acute respiratory distress syndrome: report of a Consensus Conference[J]. Ann of Intensive Care, 2014, 4:15.
[14]
Gulack BC, Hirji SA, Hartwig MG. Bridge to lung transplantation and rescue post-transplant: the expanding role of extracorporeal membrane oxygenation[J]. J Tborac Dis, 2014, 6(8):1070–1079.
[15]
Marasco SF, Vale M, Preovolos A, et al. Institution of extracorporeal membrane oxygenation late after lung transplantation-a futile exercise?[J]. Clin Transplant, 2012, 26(1):E71–77.
[16]
Pellegrion V, Hockings LE, Davies A. Veno-arterial extracorporeal membrane oxygenation for adult cardiovascular failure[J]. Curr Opin Crit Care, 2014, 20(5):484–492.
[17]
Smedira NG, Blackstone EH. Postcardiotomy mechanical support: risk factors and outcomes[J]. Ann Thorac Surg, 2001, 71(3 Suppl):S60–66.
[18]
Xie A, Phan K, Tsai YC, et al. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest: a meta-analysis[J]. J Cardiothorac Vasc Anesth, 2015, 29(3):637–645.
[19]
Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST segment elevation[J]. Eur Heart J, 2012, 33(20):2569–2619.
[20]
Diddle JW, Almodovar MC, Rajagopal SK, et al. Extracorporeal membrane oxygenation for the support of adults with acute myocarditis[J]. Crit Care Med, 2015, 43(5):1016–1025.
[21]
Aubron C, Cheng AC, Pilcher D, et al. Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohortstudy[J]. Crit Care, 2013, 17(2):R73.
[22]
Demondion P, Fournel L, Golmard JL, et al. Predictors of 30-day mortality and outcome in cases of myocardial infarction with cardiogenic shock treated by extracorporeal life support[J]. Eur J Cardiothorac Surg, 2014, 45(1):47–54.
[23]
Mosca M, Weinberg A. The Need to Develop Standardized Protocols for the Timing of Extracorporeal Membrane Oxygenation Initiation among Adult Patients in Cardiac Arrest: A Case Study[J]. J Extra Corpor Technol, 2014, 46(4):305–309.
[24]
Riou B, Adnet F, Baud F, et al. Guidelines for indications for the use of extracorporeal life support in refractory cardiac arrest[J]. Ann Fr Anesth Reanim, 2009, 28(2):182–190.
[25]
Ecc Committee, Subcomittees and Task Forces of the Amerioan Heart Association, 2005 American Heart Association guidelines for cardio Pulmonary Resuscitaion and Emergency Cardiorascular, Care[J]. circulation, 2005, 112(24 suppl):1v1–203.
[26]
Cardarelli MG, Young AJ, Griffith B. Use of extracorporeal membrane oxygenation for adults in cardiac arrest (E-CPR): A meta analysis of observation studies[J]. ASAIO J, 2009, 55(6):581–586.
[1] 董亚玲, 邓超, 刘淼淼, 张颖, 郭锋伟, 阮骊韬, 陈红, 尚佳楠, 王飞, 武慧蓉, 师桃, 宋艳. 右心室心肌应变在静脉-动脉体外膜氧合辅助支持治疗暴发性心肌炎急性期中的价值[J]. 中华危重症医学杂志(电子版), 2022, 15(04): 300-303.
[2] 陈忠垚, 陈胜灯, 李秋. 不同手术时机对原发性肝癌自发破裂出血患者远期预后的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 518-521.
[3] 刘洋, 李梦伊, 张萌, 张鹏, 张忠涛. 中国减重与代谢手术应重视的几个问题[J]. 中华普外科手术学杂志(电子版), 2023, 17(01): 11-14.
[4] 张星宇, 李炯明, 刘建和, 方克伟, 王光, 杨博伟. 无管化PCNL适应证选择及疗效观察[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 512-515.
[5] 《造口旁疝专家微共识:手术适应证及禁忌证》编审委员会, 《中华疝和腹壁外科杂志(电子版)》编辑委员会, 全国卫生产业企业管理协会疝和腹壁外科产业及临床研究分会造口旁疝专家组. 造口旁疝专家微共识:手术适应证及禁忌证[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(01): 1-2.
[6] 刘晓青, 张雪玲, 刘权兴, 罗茂雨, 戴纪刚. 肺癌术后不同时机拔除胸腔引流管临床结局比较的网状Meta分析[J]. 中华肺部疾病杂志(电子版), 2022, 15(06): 787-791.
[7] 吕垒, 冯啸, 何凯明, 曾凯宁, 杨卿, 吕海金, 易慧敏, 易述红, 杨扬, 傅斌生. 改良金氏评分在儿童肝豆状核变性急性肝衰竭肝移植手术时机评估中价值并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 661-668.
[8] 元云飞. 肝癌转化治疗后外科切除的必要性和手术时机[J]. 中华肝脏外科手术学电子杂志, 2023, 12(01): 11-15.
[9] 刘文峥, 陈勇军. 医源性胆管损伤的修复时机[J]. 中华肝脏外科手术学电子杂志, 2022, 11(06): 555-558.
[10] 隋宇航, 孙备. 慢性胰腺炎外科治疗时机与策略[J]. 中华肝脏外科手术学电子杂志, 2022, 11(05): 433-437.
[11] 尹承芬, 徐磊. 再议俯卧位通气的时机[J]. 中华重症医学电子杂志, 2023, 09(01): 9-13.
[12] 杨行建, 王守森, 孙炜. 儿童颅骨成形术理念及技术进展[J]. 中华脑科疾病与康复杂志(电子版), 2022, 12(04): 249-252.
[13] 李瑞雨, 肖凌勇, 张悦欣, 励志英, 戴晓矞. 浅析醒脑开窍针刺法治疗缺血性脑卒中肢体功能障碍针刺时机研究的思路构建与方案设计[J]. 中华针灸电子杂志, 2023, 12(04): 156-160.
[14] 漆祎鸣, 潘文志, 朱风琴, 周达新, 葛均波. 新型冠状病毒感染后经导管主动脉瓣置换术安全性分析[J]. 中华心脏与心律电子杂志, 2023, 11(02): 105-108.
[15] 汤宝鹏, 董震宇. 心肌收缩力调节器的最佳适应证人群选择[J]. 中华心脏与心律电子杂志, 2022, 10(03): 129-132.
阅读次数
全文


摘要